MKS Instruments price target lowered to $150 from $155 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on MKS Instruments (MKSI) to $150 from $155 and keeps an Overweight rating on the shares. After having hosted CEO Dr. John T.C. Lee and CFO Ram Mayampurath for a non-deal roadshow, the firm came away “more confident” that the company’s advanced packaging offering is a unique growth driver capable of offsetting the wafer fab equipment weakness, the analyst tells investors. However, the firm revised down its estimates, primarily in semi, to reflect the WFE headwinds, the analyst noted.